This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ADSTILADRIN
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
ZIRCON
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
AUA 2013 - Session Highlights: Improvements in MRI and MRS
May 7, 2013
Are preoperative Kattan and Stephenson nomograms predicting biochemical recurrence after radical prostatectomy applicable in the Chinese population? - Abstract
May 7, 2013
Effects of serum testosterone levels after 6 months of androgen deprivation therapy on the outcome of patients with prostate cancer - Abstract
May 7, 2013
Intensity-modulated radiotherapy to the pelvis and androgen deprivation in men with locally advanced prostate cancer: A study of adverse effects and their relation to quality of life - Abstract
May 7, 2013
AUA releases new clinical guideline on prostate cancer screening
May 7, 2013
AUA 2013 - Session Highlights: Salvage radiation therapy after recurrent prostate cancer: How early do we need to be?
May 6, 2013
AUA 2013 - Session Highlights: Head-to-head comparison between nomograms and multiparametric MRI to predict side specific extra capsular extension to indicate nerve sparing during radical prostatectomy
May 6, 2013
AUA 2013 - Session Highlights: Should staging transrectal saturation biopsy be a standard for assessment of disease progression and follow up for prostate cancer patients on active surveillance?
May 6, 2013
AUA 2013 - Session Highlights: Pain and quality of life (QoL) analyses from the phase 3 randomized ALSYMPCA study with radium-223 dichloride (Ra-223) in castration-resistant prostate cancer (CRPC) patients with bone metastases
May 6, 2013
AUA releases new guidelines for treating castration-resistant prostate cancer
May 6, 2013
AUA 2013 - Slide Presentation: Castration-resistant prostate cancer (CRPC): AUA Guideline
May 6, 2013
AUA 2013 - Session Highlights: Salvage Palladium brachytherapy for local failure after initial external radiotherapy for prostate cancer
May 6, 2013
AUA 2013 - Session Highlights: The impact of multiple biopsies on erectile and voiding function after radical prostatectomy: A population-based assessment
May 6, 2013
Elevated risk of prostate cancer among men with Lynch syndrome - Abstract
May 6, 2013
Risk-based prostate cancer screening: Who and how? - Abstract
May 6, 2013
Accuracy analysis in MRI-guided robotic prostate biopsy - Abstract
May 6, 2013
Cabazitaxel: A guide to its use in hormone-refractory metastatic prostate cancer - Abstract
May 6, 2013
AUA 2013 - Session Highlights: Determination of the accuracy of FDG-PET/CT in the primary staging of biological high-risk prostate cancers before local therapies: Increased uptake associated with highly aggressive tumors
May 6, 2013
AUA 2013 - Slide Presentation: Detection of Prostate Cancer: AUA Guideline
May 5, 2013
AUA 2013 - Podcast: AUA 2013 prostate cancer detection clinical guidelines
May 5, 2013
Page 1177 of 1448
Start
Prev
1172
1173
1174
1175
1176
1177
1178
1179
1180
1181
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free